Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes
AUTOR(ES)
Gonzalez, Enrique
FONTE
The National Academy of Sciences
RESUMO
Genetic variation in CC chemokine receptor 5 (CCR5), the major HIV-1 coreceptor, has been shown to influence HIV-1 transmission and disease progression. However, it is generally assumed that the same CCR5 genotype (or haplotype) has similar phenotypic effects in different populations. To test this assumption, we used an evolutionary-based classification of CCR5 haplotypes to determine their associated HIV-1 disease-modifying effects in a large well-characterized racially mixed cohort of HIV-1-seropositive individuals. We demonstrate that the spectrum of CCR5 haplotypes associated with disease acceleration or retardation differs between African Americans and Caucasians. Also, we show that there is a strong interactive effect between CCR5 haplotypes with different evolutionary histories. The striking population-specific phenotypic effects associated with CCR5 haplotypes emphasize the importance of understanding the evolutionary context in which disease susceptibility genes are expressed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18402Documentos Relacionados
- Endpoints and Analyses to Discern Disease-Modifying Drug Effects in Early Parkinson’s Disease
- Glucosamine: A potential disease-modifying agent in osteoarthritis?
- Evidence for early disease-modifying drugs in rheumatoid arthritis
- Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120
- Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review
